Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnanciesGynecologic oncology, 2011-05, Vol.121 (2), p.290 [Peer Reviewed Journal]Copyright © 2010 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2010.12.345 ;PMID: 21255824Digital Resources/Online E-Resources |
|
22 |
Material Type: Article
|
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)Gynecologic oncology, 2020-04, Vol.157 (1), p.161 [Peer Reviewed Journal]Copyright © 2019 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2019.12.034 ;PMID: 31924334Digital Resources/Online E-Resources |
|
23 |
Material Type: Article
|
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancerGynecologic oncology, 2015-10, Vol.139 (1), p.10 [Peer Reviewed Journal]Copyright © 2015 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.08.004 ;PMID: 26271155Digital Resources/Online E-Resources |
|
24 |
Material Type: Article
|
Body mass index and mortality in endometrial cancer: A systematic review and meta-analysisGynecologic oncology, 2016-01, Vol.140 (1), p.184 [Peer Reviewed Journal]Copyright © 2015 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.10.020 ;PMID: 26524722Digital Resources/Online E-Resources |
|
25 |
Material Type: Article
|
Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologistsGynecologic oncology, 2017-03, Vol.144 (3), p.637 [Peer Reviewed Journal]Copyright © 2016 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2016.12.003 ;PMID: 28057354Digital Resources/Online E-Resources |
|
26 |
Material Type: Article
|
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trialGynecologic oncology, 2013-03, Vol.128 (3), p.449 [Peer Reviewed Journal]Copyright © 2012 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2012.09.025 ;PMID: 23022593Digital Resources/Online E-Resources |
|
27 |
Material Type: Article
|
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositionsGynecologic oncology, 2015-01, Vol.136 (1), p.3 [Peer Reviewed Journal]Copyright © 2014 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2014.09.009 ;PMID: 25238946Digital Resources/Online E-Resources |
|
28 |
Material Type: Article
|
Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancerGynecologic oncology, 2016-11, Vol.143 (2), p.319 [Peer Reviewed Journal]Copyright © 2016 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2016.09.009 ;PMID: 27640961Digital Resources/Online E-Resources |
|
29 |
Material Type: Article
|
Endometrial cancer: a review and current management strategies: part IIGynecologic oncology, 2014-08, Vol.134 (2), p.393 [Peer Reviewed Journal]Copyright © 2014 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2014.06.003 ;PMID: 24929052Digital Resources/Online E-Resources |
|
30 |
Material Type: Article
|
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancerGynecologic oncology, 2016-05, Vol.141 (2), p.293 [Peer Reviewed Journal]Crown Copyright © 2016. Published by Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2016.03.008 ;PMID: 26972336Digital Resources/Online E-Resources |
|
31 |
Material Type: Article
|
Uterine carcinosarcoma: A review of the literatureGynecologic oncology, 2015-06, Vol.137 (3), p.581 [Peer Reviewed Journal]Copyright © 2015 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.03.041 ;PMID: 25805398Digital Resources/Online E-Resources |
|
32 |
Material Type: Article
|
The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancerGynecologic oncology, 2015-04, Vol.137 (1), p.173 [Peer Reviewed Journal]Copyright © 2015 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.02.003 ;PMID: 25677064Digital Resources/Online E-Resources |
|
33 |
Material Type: Article
|
Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) IGynecologic oncology, 2016-01, Vol.140 (1), p.8 [Peer Reviewed Journal]EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.09.077 ;PMID: 26428940Digital Resources/Online E-Resources |
|
34 |
Material Type: Article
|
Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratificationGynecologic oncology, 2020-07, Vol.158 (1), p.3 [Peer Reviewed Journal]Copyright © 2020 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2020.04.043 ;PMID: 32331700Digital Resources/Online E-Resources |
|
35 |
Material Type: Article
|
Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapyGynecologic oncology, 2015-05, Vol.137 (2), p.343 [Peer Reviewed Journal]Copyright © 2015. Published by Elsevier Inc. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.02.017 ;PMID: 25725131Digital Resources/Online E-Resources |
|
36 |
Material Type: Article
|
Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic reviewGynecologic oncology, 2012-05, Vol.125 (2), p.477 [Peer Reviewed Journal]Copyright © 2012 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2012.01.003 ;PMID: 22245711Digital Resources/Online E-Resources |
|
37 |
Material Type: Article
|
Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for managementGynecologic oncology, 2018-11, Vol.151 (2), p.381 [Peer Reviewed Journal]Copyright © 2018 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2018.09.001 ;PMID: 30217369Digital Resources/Online E-Resources |
|
38 |
Material Type: Article
|
Chemotherapy-induced peripheral neuropathy: Current status and progressGynecologic oncology, 2016-01, Vol.140 (1), p.176 [Peer Reviewed Journal]Copyright © 2015 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.11.011 ;PMID: 26556766Digital Resources/Online E-Resources |
|
39 |
Material Type: Article
|
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysisGynecologic oncology, 2013-09, Vol.130 (3), p.493 [Peer Reviewed Journal]Copyright © 2013 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2013.05.040 ;PMID: 23747291Digital Resources/Online E-Resources |
|
40 |
Material Type: Article
|
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapyGynecologic oncology, 2016-02, Vol.140 (2), p.199 [Peer Reviewed Journal]Copyright © 2016 Elsevier Inc. All rights reserved. ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2015.12.020 ;PMID: 26723501Digital Resources/Online E-Resources |